Form 4: Oscar Health Executive Sells Shares After Stock Unit Vesting

Oscar Health's President of Technology & CTO, Mario Schlosser, sold shares to cover tax obligations after restricted stock units vested.

Summary

• Mario Schlosser, President of Technology & CTO at Oscar Health, sold a total of 6,516 Class A common stock shares on December 2, 2024.
• These sales were executed in multiple transactions at weighted average prices of $18.07 and $18.48 per share.
• The sales were made to cover tax obligations arising from the vesting of 14,412 restricted stock units on December 1, 2024.
• Following these transactions, Schlosser directly owns 81,962 shares of Class A common stock and 129,705 restricted stock units.

Sentiment

Score: 5

Explanation: The document reflects a routine transaction related to executive compensation and does not indicate any positive or negative sentiment.

Industry Context

This is a routine transaction for executives who receive equity compensation. It is common for executives to sell shares to cover tax obligations when restricted stock units vest.

Comparison to Industry Standards

• Executive stock sales are a common occurrence in publicly traded companies, particularly after vesting periods for equity awards.
• The sale of shares to cover tax obligations is a standard practice among executives receiving stock-based compensation.
• Companies like UnitedHealth Group (UNH) and Humana (HUM) also see similar transactions by their executives, as reported in their respective SEC filings.

Stakeholder Impact

• The sale of shares by an executive may have a minor impact on the stock price, but it is generally considered a normal part of executive compensation.

Key Dates

Keywords

Oscar Health, insider trading, stock sale, restricted stock units, Form 4, equity compensation, tax obligations, Mario Schlosser